MoU signed between Ministry of Ayush and Department of Biotechnology
MoU will facilitate Inter-Ministerial Cooperation for evidence-based biotechnological interventions in the Ayush sector
A Memorandum of Understanding (MoU) was signed between the Ministry of Ayush and the Department of Biotechnology, Government of India for mutual collaboration to explore the possibility of cooperation, convergence and synergy to bring out the expertise under one platform toward evidence-based biotechnological interventions in Ayush sector. Secretary, Ministry of Ayush Vaidya Rajesh Kotecha and Secretary, Department of Biotechnology Dr Rajesh S Gokhale were present on this occasion along with another official of both the ministries.
Through this association, it is expected that traditional healthcare and biotechnology together would enable tremendous possibilities to undertake innovative and path-breaking research, which can be used for the exploration of various fundamental principles of Ayush systems. There is a need for multi-pronged and technological ways for the exploration and application of this ancient scientific system of health care into the public health care domain.
Biotechnological R & D and Ayush Interventions will improve quality of life as well as life span (Vayahsthaapana Rasayana) and bring down the associated morbidity pertaining to chronic diseases such as diabetes, obesity, cardiovascular disease, osteoarthritis, cachexia, pain management and infectious diseases for example Tuberculosis.
On this occasion, Vaidya Rajesh Kotecha said that the MoU between the Ministry of Ayush and DBT is expected to pave way for coordinated research in the Ayush sector and the huge untapped potential of the Ayush health care system may be utilized for the community benefit.
Addressing the gathering, Dr Rajesh S Gokhale said that this Inter-Ministerial cooperation between the Ministry of Ayush and DBT is expected to generate knowledge and new means of intervention strategies for difficult to treat diseases.
This joint R&D effort ranging from fundamental science to validation and thereafter product development will significantly help in the growth of the Indian contributions to this important sector, not only nationally but internationally as well. Emphasis would be given to mechanistic studies of Ayurveda Therapeutics using animal models of disease and other advanced analytical methods along with data analytical tools.
Disclaimer : This is an official press release by PIB.